Tina Wang is a Senior Manager at CIRS - Centre for Innovation in Regulatory Science, where Tina leads the HTA Programme and Strategic Partnerships. With a strong background in research and analysis within the regulatory and HTA fields, Tina has also worked at Utrecht University as a Phd Researcher and at GlaxoSmithKline as a New Product Introduction Scientist. Tina's educational background includes a PhD from Utrecht University, an MSc in Pharmaceutical Analysis and Quality Control from King's College London, and a BSc in Chemistry from Beijing University of Technology. Tina has also pursued short courses in Health Economics, Policy and Management, Pharmaceutical Economics and Policy at The London School of Economics and Political Science.
This person is not in any teams
CIRS - Centre for Innovation in Regulatory Science
The Centre for Innovation in Regulatory Science (CIRS) is a neutral, independently managed UK-based subsidiary of Clarivate plc. CIRS provides an international forum for industry, regulators, HTA and other healthcare stakeholders to meet, debate and develop regulatory and reimbursement policy through the innovative application of regulatory science and to facilitate access to pharmaceutical products. It is governed and operated by Clarivate for the sole support of its members’ activities. The organisation has its own dedicated management and advisory boards, and its funding is derived from membership dues, related activities, special projects and grants.